Retraction notice to "miR-217 inhibits proliferation, migration, and invasion via targeting AKT3 in thyroid cancer" [Biomed. Pharmacother. 95 (2017) 1718-1724]
Biomed Pharmacother. 2024 Feb:171:116187.
doi: 10.1016/j.biopha.2024.116187.
Epub 2024 Jan 30.